AMPX

AMPX - Amprius Technologies Inc

OPPORTUNISTIC BUYAWAIT ENTRY2026-08-08Data 15 days oldUSD 11.85

Conviction

out of 100

Executive Summary

Amprius Technologies Inc is a US manufacturer of high-energy and high-power lithium-ion batteries built around a silicon-anode chemistry, producing what the company describes as the industry's highest energy density cells. The business sells into applications where weight and energy density are critical, principally aerospace and high-altitude pseudo-satellite (HAPS) platforms, defence programmes, and selected premium electric-mobility customers. Manufacturing is anchored at the company's facility in Fremont, California, with a second site in Gainesville, Georgia scaling the silicon-anode platform for broader volume production.

The investment case rests on the company translating the commercial traction already evident in the Q2 2026 print into a sustained revenue ramp through 2027, with the next hard catalyst being the Q3 2026 results, expected in early November 2026 and the next scheduled validation of the recently raised full-year guidance. For the thesis to work, Amprius needs to keep converting its silicon-anode pipeline into firm volume orders while improving gross margin enough to narrow the operating cash burn before any further equity issuance. The primary risk, as disclosed in the company's 10-K, is that the company remains loss-making at the operating line, may require additional capital, and faces unresolved technical questions about silicon-anode durability under repeated cycling.

OPPORTUNISTIC BUY. Conviction Score: 56/100. The view would shift higher on a confirmed multi-year OEM supply agreement or a clean move to gross-margin-positive territory, and would shift lower on a further dilutive equity raise or a publicly disclosed durability field failure.

Wait for entry. Current price USD 11.85 is 29.2% above the buy ceiling of USD 9.17. New positions only below the ceiling.

AWAIT ENTRYOPPORTUNISTIC BUY · 56/100Now USD 11.85 · buy ≤ USD 9.17 · trim ≥ USD 13.50

Thesis break: A reset of full-year 2026 revenue guidance lower at the Q3 2026 print, a further dilutive equity raise at a material discount, or a publicly disclosed silicon-anode durability failure with a key aviation or defence customer.

Business Model

Amprius generates revenue by designing, manufacturing and selling rechargeable lithium-ion battery cells built around a 100% silicon anode, rather than the graphite anodes used in conventional cells. Cells are sold in proprietary formats that are then integrated by customers into battery packs for end applications. The company does not disclose a granular revenue split by end market, but management's commentary on the Q2 2026 earnings call and the investor presentation point to three principal demand pools: aviation and HAPS, defence, and a smaller book of premium light-electric-vehicle and specialty programmes.

The economics of the business are still in build-out. Q2 2026 revenue of USD 34.03 million (per the 8-K filed on 4 August 2026) was a quarterly record, but the company remains unprofitable at the operating line and continues to consume cash. The competitive moat, if one exists, sits in the company's silicon-anode IP and its position as a US-domiciled cell manufacturer serving aerospace and defence customers with US content requirements; peer comparison data is sparse, and the company does not publish a like-for-like benchmark against established graphite-anode competitors.

Customer concentration is not quantified in the public materials reviewed, but management has indicated that the order book is being built around a small number of programme-level relationships rather than a broad catalogue of small buyers. This means quarterly revenue can move sharply with the timing of a handful of customer deliveries, which is a feature of the model investors need to underwrite.

Financial Snapshot

Price

USD 11.85

Market Cap

USD 1.7bn

52w High

USD 24.23

52w Low

USD 6.36

Distance from 52wH

-51.1%

Beta

2.33

Avg Volume

6811376

Currency

USD

Recent Catalysts

[4 August 2026] - Amprius filed an 8-K announcing second-quarter 2026 financial results, reporting record quarterly revenue of USD 34.03 million and raising full-year 2026 guidance. Source: SEC Form 8-K, Amprius Technologies Inc.

[4 August 2026] - The accompanying earnings press release (Exhibit 99.1 to the 8-K) detailed the guidance increase and recent business highlights, including manufacturing and customer-programme progress. Source: Amprius Technologies Inc press release, Exhibit 99.1 to Form 8-K.

[Q2 2026, quarter ended 30 June 2026] - Yahoo Finance coverage of the Q2 2026 results noted record revenue and the guidance raise; the article also flagged that the company remained loss-making at the operating line, in line with prior quarters. Source: Yahoo Finance earnings coverage.

[Q1 2026, quarter ended 31 March 2026] - Amprius reported Q1 2026 earnings per share of USD (0.04), versus consensus of USD (0.02), with results filed via the company's quarterly investor relations materials. Source: Amprius Technologies Inc investor relations, Q1 2026 results page.

[Upcoming, expected early November 2026] - The next scheduled reporting event is the Q3 2026 results, due in early November 2026, which will be the first test of the raised full-year 2026 guidance. Source: Amprius Technologies Inc investor relations calendar.

Thesis Evaluation

Bull Case (23% weight)

Amprius converts the HAPS and defence pipeline into multi-year offtake agreements, lifts the Gainesville line to nameplate, and moves the gross margin towards break-even as fixed costs absorb revenue. Under those conditions, the recent analyst price targets implying 94-156% upside from the current price become credible, supporting a 12-month price target of $18.00.

Base Case (49% weight)

The company delivers on its freshly raised 2026 guidance, revenue continues to grow sequentially from the Q2 2026 record of USD 34.03 million, and operating losses narrow modestly without a major capital raise in the next 12 months. With execution proceeding but no step-change in margin or customer breadth, a 12-month price target of $13.50 is the most likely outcome.

Bear Case (28% weight)

Operating losses persist, silicon-anode cycle-life concerns deter large-scale adoption, and Amprius is forced to raise additional equity on dilutive terms, pushing the share count materially higher. In that scenario the stock revisits its 2025-2026 lows, implying a 12-month downside target of $7.00.

Weighted conviction:Bull (23%) x 100 + Base (49%) x 62 + Bear (28%) x 10 = 56/100. OPPORTUNISTIC BUY.

Key Risks

Continuing operating losses and cash burn: Amprius has a disclosed history of losses and expects significant expenses and continuing losses for the foreseeable future, with Q2 2026 still loss-making at the operating line. Estimated probability: 70%. Impact: severe.
Need for additional capital and dilution risk: The 10-K states that Amprius may require additional capital to fund growth and that financing may not be available on reasonable terms, which could result in dilutive equity issuance. Estimated probability: 55%. Impact: severe.
Silicon-anode durability and cycle-life risk: The 10-K flags that silicon particles can expand by up to 300% during charging, raising the prospect of mechanical degradation and field failures that could undermine customer adoption. Estimated probability: 35%. Impact: severe.
Manufacturing scale-up execution risk: Amprius is scaling a second manufacturing site in Gainesville, Georgia, and ramp-up delays, yield issues or supply-chain bottlenecks could push out the revenue trajectory underpinning current guidance. Estimated probability: 45%. Impact: moderate.
Customer concentration and programme timing risk: Revenue appears to be driven by a small number of programme-level customer relationships, meaning delivery timing slips by even one key customer can materially affect quarterly results. Estimated probability: 50%. Impact: moderate.

Who Should Own It / Avoid It

Ideal for: Speculative growth investors with a high tolerance for equity volatility and the capacity to absorb a potentially dilutive raise, who can underwrite a minimum 18-24 month holding period to allow the Gainesville ramp and 2027 earnings cycle to play out, and who are comfortable with single-stock position sizing well below their core index holdings.

Avoid if: Investors requiring current cash earnings or a near-term path to GAAP profitability, those unable to tolerate a further equity raise that meaningfully expands the share count, or anyone needing a deep public-comparable peer set to value the position, since the silicon-anode category is thinly traded and benchmarking data is limited.

Recommendation

OPPORTUNISTIC BUY - 56/100. The combination of record Q2 2026 revenue of USD 34.03 million and the raised full-year 2026 guidance is a tangible hard catalyst that the market has begun to price in, and a measured long is warranted for investors who can tolerate the underlying loss-making profile. The call would upgrade towards a higher conviction tier on confirmation of a named multi-year OEM supply agreement or a clearly signalled path to gross-margin-positive quarterly results. It would degrade on a further dilutive equity raise at a discount to market, a publicly disclosed silicon-anode field failure with a major customer, or guidance being reset lower at the Q3 2026 print expected in early November 2026. At the current price of $11.85 the shares trade above our buy ceiling of $9.17: the thesis is credible but the price is not - new positions only below that level.

The probability-weighted value across our three scenarios is $12.72, 7% above the current price of $11.85 - the market has not yet priced our probability-weighted view. Levels below are derived from the scenario targets and probabilities above, not from percentage offsets to today's price.

BUY

below $9.17 - below this level the upside to the base-case target ($13.50) is at least 2x the downside to the bear case ($7.00), the minimum risk/reward we require before committing new capital.

HOLD

between $9.17 and $13.50 - the base case is not yet fully priced, so existing holders are paid to wait, but new money gets no margin of safety in this zone.

REDUCE

above $13.50 - at this level the base case is fully reflected in the price and anything beyond it is paying for a bull scenario we weight at 23%.

SELL

if A reset of full-year 2026 revenue guidance lower at the Q3 2026 print, a further dilutive equity raise at a material discount, or a publicly disclosed silicon-anode durability failure with a key aviation or defence customer, regardless of price - the bear target of $7.00 is the backstop, not an arbitrary percentage stop.

Conviction Trend

Latest conviction: 56/100. Trend versus prior report: Initiation.

CONVICTION BUY (80+)BUY (65 - 79)OPP BUY (50 - 64)SPEC BUY (30 - 49)AVOID (0 - 29)

Report date	Conviction
2026-08-08	56

See the trade-card view →

Sources

Market data: DYOR HQ proprietary market data workflow.

Public sentiment and news flow: Public news flow and earnings coverage, company earnings press releases and investor relations materials, regulatory filings on EDGAR, and aggregated analyst commentary distributed through financial data platforms such as TipRanks and MarketBeat.

Primary source types: SEC filings (Form 8-K and the underlying 10-K risk-factor disclosures), earnings call transcripts and accompanying press releases, company investor relations materials (quarterly results pages and presentations), and third-party earnings coverage summarising those primary disclosures.

Key sources

Data correct as of 2026-08-08